coronary chronic total occlusion
Conditions
Interventions
Sponsors
Eligibility
Inclusion criteria
Inclusion criteria: (1) Patients aged 18 to 85; (2) The target lesion requiring interventional treatment is confirmed coronary chronic total occlusion (CTO); (3) Agree to enroll in this study and sign the informed consent form.
Exclusion criteria
Exclusion criteria: 1.Admitted to the hospital with a diagnosis of acute ST-elevation myocardial infarction; 2.Patients with heart failure and respiratory failure who are unable to lie flat; 3.History of contrast allergy; 4.Acute and chronic infectious diseases (severe pneumonia, etc.); 5.Recent history of hemorrhagic stroke (within half a year); 6.Severe liver (total bilirubin >3ULN) and renal insufficiency (EGFR<15ml/min/1.73m^2) caused by various reasons; 7.History of various cardiomyopathy; 8.Severe anemia, thrombocytopenia and other hematologic diseases; 9.Patients with malignant tumors, autoimmune diseases, glucocorticoids and immunosuppressants for various reasons; 10.Pregnant women, lactating women, and patients with pregnancy plans during this trial. 11. Participation in other interventional clinical studies or those who, in the opinion of the investigator, are not suitable to participate in this study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Manipulation time; | — |
Secondary
| Measure | Time frame |
|---|---|
| Total surgery time;Surgical radiation dose; | — |
Countries
China
Contacts
Zhongshan Hospital, Fudan University